Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17
- PMID: 31503384
- PMCID: PMC6982538
- DOI: 10.1111/add.14812
Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17
Abstract
Background and aims: Due to their small sample sizes, geographic specificity and limited examination of socio-demographic characteristics, recent studies of methamphetamine use among people using heroin in the United States are limited in their ability to identify national and regional trends and to characterize populations at risk for using heroin and methamphetamine. This study aimed to examine trends and correlates of methamphetamine use among heroin treatment admissions in the United States.
Design: Longitudinal analysis of data from the 2008 to 2017 Treatment Episode Data Set. Descriptive statistics, trend analyses and multivariable logistic regression were used to examine characteristics associated with methamphetamine use among heroin treatment admissions.
Setting: United States.
Participants: Treatment admissions of people aged ≥ 12 years whose primary substance of use is heroin.
Measurements: Primary measurement was heroin treatment admissions involving methamphetamine. Secondary measurements were demographics of sex, age, race/ethnicity, US census region, living arrangement and employment status.
Findings: The percentage of primary heroin treatment admissions reporting methamphetamine use increased each year from 2.1% in 2008 to 12.4% in 2017, a relative percentage increase of 490% and an annual percentage change (APC) of 23.4% (P < 0.001). During the study period, increases were seen among males and females and among all demographic and geographic groups examined. Among primary heroin treatment admissions reporting methamphetamine use in 2017, 47.1% reported injecting, 46.0% reported smoking, 5.1% reporting snorting and 1.8% reported oral/other as their usual route of methamphetamine use.
Conclusions: Methamphetamine use among heroin treatment admissions in the United States increased from one in 50 primary heroin treatment admissions in 2008 to one in 8 admissions in 2017.
Keywords: Heroin; injection drug use; methamphetamine; opioid overdose; opioid use disorder; overdose death; synthetic opioids.
Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
Conflict of interest statement
Figures
Comment in
-
Safer smoking kits for methamphetamine consumption.Addiction. 2020 Jun;115(6):1189-1190. doi: 10.1111/add.14914. Epub 2020 Jan 24. Addiction. 2020. PMID: 31783431 No abstract available.
-
Reducing negative consequences from use of methamphetamine.Addiction. 2020 Jun;115(6):1190-1191. doi: 10.1111/add.14966. Epub 2020 Jan 27. Addiction. 2020. PMID: 31925828 No abstract available.
References
-
- Public Health Agency of Canada. Special Advisory Committee on the Epidemic of Opioid Overdoses. Highlights from phase one of the national study on opioid- and other drug-related overdose deaths: insights from coroners and medical examiners. Ottawa: Public Health Agency of Canada; September 2018. Available at: https://www.canada.ca/en/public-health/services/publications/healthy-liv...
-
- Australian Institute of Health and Welfare. Australia’s Health 2018. Available at: https://www.aihw.gov.au/getmedia/3a734af9-5ee4-490e-9a8d-2702907aed25/ai...
-
- European Monitoring Centre for Drugs and Drug Addiction. European Drug Report: Trends and Developments. 2019. Available at: http://www.emcdda.europa.eu/system/files/publications/11364/20191724_TDA...
-
- United Nations Office on Drugs and Crime. World Drug Report 2018. Available at: https://www.unodc.org/wdr2018/
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
